Development of methodology for identification of simultaneous determination of nifedipine, enalapril and bisoprolol

Authors

  • L. S. Logoyda I. Horbachevsky Ternopil State Medical University

DOI:

https://doi.org/10.11603/mcch.2410-681X.2017.v0.i4.8307

Keywords:

nifedipine, enalapril maleate, bisoprolol fumarate, identification, thin layer chromatography, validation.

Abstract

Introduction. Active pharmaceutical ingredient (API) can often be measured by several methods and the choice of analytical method involves many considerations, such as chemical properties of the analyte, concentrations levels, sample matrix, cost of the analysis, and speed of the analysis, quantitative or qualitative measurement, and precision required and necessary equipment. Thin-layer chromatography (TLC) is a chromatography technique used to separate non-volatile mixtures. TLC can be used to help determine the number of components in a mixture, the identity of compounds, and the purity of a compound. By observing the appearance of a product or the disappearance of a reactant, it can also be used to monitor the progress of a reaction.

The aim of the study – to develop more rapid, simple, selective, less expensive methods of TLC analysis of simultaneous determination of nifedipine, enalapril and bisoprolol and for using this method of analysis in future for development of bioanalytical methods and pharmacokinetic study.

Research Methods. The present study assessed mobile phases of nifedipine, enalapril and bisoprolol for TLC.

Results and Discussion. Method of simultaneous identification of nifedipine, enalapril and bisoprolol by TLC was developed. It was established that the most optimal Rf observed using mobile phases for simultaneous determination of nifedipine, enalapril and bisoprolol: chloroform-methanol (9:1). We explored the validation characteristics – specificity and suitability of the chromatographic system that met, the eligibility criteria established by the SPU.

Conclusion. We developed chromatographic methods for simultaneous determination of nifedipine, enalapril and bisoprolol. Propects for future research will be aimed at developing bioanalytical methods of analysis.

Author Biography

L. S. Logoyda, I. Horbachevsky Ternopil State Medical University

 

References

Patil, R., Deshmukh, T., Patil, V., & Khandelwal, K. (2014). Review on analytical method development and validation. Research and reviews. Journal of Pharmaceutical Analysis, 3 (3), 1-10.

ICH Topic Q2 (R1) Validation of Analytical Procedures: Text and methodology.

Liliya, L. Dmutro, K., & Stanislav, S. (2016). Development of methods for identification of calcium channel blockers in medicines. International Journal of Research Ayurveda Pharmaceutical, 7 (2), 88-91.

Logoyda Liliya. (2017) Development and methodology for the estimation of bisoprolol in pharmaceuticals. Medical and clinical chemistry, 2, 34-37.

Logoyda, L. (2015). Development and validation of new methods of analysis for the determination of different natural and synthetic original active pharmaceutical ingredients in medicines. Duphat, 48.

Logoyda, L. Validation of chromatographic methods of analysis for the determination of active pharmaceutical ingredients in different medicines. Pharma. School Association for Pharmaceutical Development and Scientific Research, 34.

Published

2018-01-11

How to Cite

Logoyda, L. S. (2018). Development of methodology for identification of simultaneous determination of nifedipine, enalapril and bisoprolol. Medical and Clinical Chemistry, (4), 57–60. https://doi.org/10.11603/mcch.2410-681X.2017.v0.i4.8307

Issue

Section

ORIGINAL INVESTIGATIONS